Piramal Pharma Solutions
FDA Approved Drugs

Piramal Pharma Solutions

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 20
  • Latest Approval Date May 14, 2025
  • Data Source FDA
  • First Approval Date Jun 27, 1995
Company Overview

Company

Piramal Pharma Solutions

Country

U.S.A

Website

Visit Website

Email

contact.us@piramal.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Piramal Pharma Solutions

18655 Krause St, Riverview, MI 48193

U.S.A

www.piramalpharmasolutions.com/ contact.us@piramal.com View on Map
FDA Approved Drug Records ( 20 records )
2018
01 Aug
RX Application: 210207

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2018-08-01

210207 / 1

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

210207

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2018-08-01

Regulatory Status

RX

2018
01 Aug
RX Application: 210207

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2018-08-01

210207 / 2

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

210207

Product Number

2

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2018-08-01

Regulatory Status

RX

2018
01 Aug
RX Application: 210207

Drug Name

CINACALCET HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 90MG BASE

Approval Date

2018-08-01

210207 / 3

Active Ingredient

CINACALCET HYDROCHLORIDE

Application Number

210207

Product Number

3

Dosage Form

-

Strength

EQ 90MG BASE

Approval Date

2018-08-01

Regulatory Status

RX

2022
11 Mar
RX Application: 212432

Drug Name

CISATRACURIUM BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2022-03-11

212432 / 1

Active Ingredient

CISATRACURIUM BESYLATE

Application Number

212432

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2022-03-11

Regulatory Status

RX

2022
11 Mar
RX Application: 212432

Drug Name

CISATRACURIUM BESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2022-03-11

212432 / 2

Active Ingredient

CISATRACURIUM BESYLATE

Application Number

212432

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2022-03-11

Regulatory Status

RX

2018
22 Oct
RX Application: 209808

Drug Name

CLOBAZAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-10-22

209808 / 1

Active Ingredient

CLOBAZAM

Application Number

209808

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-10-22

Regulatory Status

RX

2018
22 Oct
RX Application: 209808

Drug Name

CLOBAZAM

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2018-10-22

209808 / 2

Active Ingredient

CLOBAZAM

Application Number

209808

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2018-10-22

Regulatory Status

RX

2019
30 Dec
RX Application: 212995

Drug Name

DEFERASIROX

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2019-12-30

212995 / 1

Active Ingredient

DEFERASIROX

Application Number

212995

Product Number

1

Dosage Form

-

Strength

90MG

Approval Date

2019-12-30

Regulatory Status

RX

2019
30 Dec
RX Application: 212995

Drug Name

DEFERASIROX

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2019-12-30

212995 / 2

Active Ingredient

DEFERASIROX

Application Number

212995

Product Number

2

Dosage Form

-

Strength

360MG

Approval Date

2019-12-30

Regulatory Status

RX

2020
15 Jun
RX Application: 212995

Drug Name

DEFERASIROX

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

212995 / 3

Active Ingredient

DEFERASIROX

Application Number

212995

Product Number

3

Dosage Form

-

Strength

180MG

Approval Date

2020-06-15

Regulatory Status

RX

1995
27 Jun
RX Application: 74502

Drug Name

ISOFLURANE

Product Number

1

Dosage Form

-

Strength

99.9%

Approval Date

1995-06-27

74502 / 1

Active Ingredient

ISOFLURANE

Application Number

74502

Product Number

1

Dosage Form

-

Strength

99.9%

Approval Date

1995-06-27

Regulatory Status

RX

2025
14 May
RX Application: 210718

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;20MG

Approval Date

2025-05-14

210718 / 1

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

210718

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;20MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 210718

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;40MG

Approval Date

2025-05-14

210718 / 2

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

210718

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE;12.5MG;40MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 210718

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;25MG;40MG

Approval Date

2025-05-14

210718 / 3

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

210718

Product Number

3

Dosage Form

-

Strength

EQ 5MG BASE;25MG;40MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 210718

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;40MG

Approval Date

2025-05-14

210718 / 4

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

210718

Product Number

4

Dosage Form

-

Strength

EQ 10MG BASE;12.5MG;40MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 210718

Drug Name

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;40MG

Approval Date

2025-05-14

210718 / 5

Active Ingredient

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Application Number

210718

Product Number

5

Dosage Form

-

Strength

EQ 10MG BASE;25MG;40MG

Approval Date

2025-05-14

Regulatory Status

RX

2023
25 Jul
RX Application: 213085

Drug Name

RANOLAZINE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2023-07-25

213085 / 1

Active Ingredient

RANOLAZINE

Application Number

213085

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2023-07-25

Regulatory Status

RX

2023
25 Jul
RX Application: 213085

Drug Name

RANOLAZINE

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2023-07-25

213085 / 2

Active Ingredient

RANOLAZINE

Application Number

213085

Product Number

2

Dosage Form

-

Strength

1GM

Approval Date

2023-07-25

Regulatory Status

RX

2024
23 Jul
RX Application: 217115

Drug Name

VARENICLINE TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2024-07-23

217115 / 1

Active Ingredient

VARENICLINE TARTRATE

Application Number

217115

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2024-07-23

Regulatory Status

RX

2024
23 Jul
RX Application: 217115

Drug Name

VARENICLINE TARTRATE

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2024-07-23

217115 / 2

Active Ingredient

VARENICLINE TARTRATE

Application Number

217115

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2024-07-23

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    29 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    20 View
Drug Status Breakdown
20 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

CINACALCET HYDROCHLORIDE

Application Number

210207

Product Number

1

Active Ingredient

CINACALCET HYDROCHLORIDE

Dosage Form

-

Strength

EQ 30MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit